Welcome!

News Feed Item

Cardiac Arrest Global Clinical Trials Review, H1, 2014

NEW YORK, Feb. 12, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Cardiac Arrest Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiac Arrest. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiac Arrest. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cardiac Arrest 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cardiac Arrest 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Cardiac Arrest Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Cardiac Arrest 33
Nov 07, 2012: Metformin Offers Cardio Benefits Over Sulfonylureas In Diabetes, Study Finds 33
Aug 22, 2012: NIH Launches Trial To Evaluate Anti-inflammatory Treatment For Preventing Heart Attacks, Strokes, And Cardiovascular Deaths 33
Aug 22, 2012: Brigham And Women's Hospital Researchers Initiate Major Cardiovascular Inflammation Reduction Trial Using Teva's Trexall 34
Mar 25, 2012: Infusion Of Abciximab Into Coronary Artery May Reduce Size Of Heart Damage After Heart Attack 35
Nov 13, 2011: Anti-Clotting Drug Lowers Risks In Acute Coronary Syndrome Treatment 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Janssen Global Services, LLC 37
Clinical Trial Overview of Janssen Global Services, LLC 37
Boston Scientific Corporation 38
Clinical Trial Overview of Boston Scientific Corporation 38
Biotronik SE & Co. KG 39
Clinical Trial Overview of Biotronik SE & Co. KG 39
PT Dexa Medica 40
Clinical Trial Overview of PT Dexa Medica 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Janssen-Cilag A.G. 42
Clinical Trial Overview of Janssen-Cilag A.G. 42
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of Top Institutes / Government 44
Ottawa Hospital Research Institute 44
Clinical Trial Overview of Ottawa Hospital Research Institute 44
University of Washington 45
Clinical Trial Overview of University of Washington 45
National Heart, Lung, and Blood Institute 46
Clinical Trial Overview of National Heart, Lung, and Blood Institute 46
Kyoto University 47
Clinical Trial Overview of Kyoto University 47
Medical University of Vienna 48
Clinical Trial Overview of Medical University of Vienna 48
University of Pennsylvania 49
Clinical Trial Overview of University of Pennsylvania 49
Sunnybrook Health Sciences Centre 50
Clinical Trial Overview of Sunnybrook Health Sciences Centre 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
University Hospital Basel 52
Clinical Trial Overview of University Hospital Basel 52
National Taiwan University Hospital 53
Clinical Trial Overview of National Taiwan University Hospital 53
Five Key Clinical Profiles 54
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Cardiac Arrest Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 37
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014* 38
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2014* 39
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by PT Dexa Medica, 2014* 40
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 41
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2014* 42
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 44
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 45
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 46
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 47
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 48
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 49
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 50
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 51
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 52
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 53

List of Figures

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 76

To order this report: Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportuni...
"We host and fully manage cloud data services, whether we store, the data, move the data, or run analytics on the data," stated Kamal Shannak, Senior Development Manager, Cloud Data Services, IBM, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
IoT is rapidly changing the way enterprises are using data to improve business decision-making. In order to derive business value, organizations must unlock insights from the data gathered and then act on these. In their session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, and Peter Shashkin, Head of Development Department at EastBanc Technologies, discussed how one organization leveraged IoT, cloud technology and data analysis to improve customer experiences and effi...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develo...
SYS-CON Events announced today that MangoApps will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. MangoApps provides modern company intranets and team collaboration software, allowing workers to stay connected and productive from anywhere in the world and from any device.
The IETF draft standard for M2M certificates is a security solution specifically designed for the demanding needs of IoT/M2M applications. In his session at @ThingsExpo, Brian Romansky, VP of Strategic Technology at TrustPoint Innovation, explained how M2M certificates can efficiently enable confidentiality, integrity, and authenticity on highly constrained devices.
“delaPlex Software provides software outsourcing services. We have a hybrid model where we have onshore developers and project managers that we can place anywhere in the U.S. or in Europe,” explained Manish Sachdeva, CEO at delaPlex Software, in this SYS-CON.tv interview at @ThingsExpo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor – all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
The IoT is changing the way enterprises conduct business. In his session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, discussed how businesses can gain an edge over competitors by empowering consumers to take control through IoT. He cited examples such as a Washington, D.C.-based sports club that leveraged IoT and the cloud to develop a comprehensive booking system. He also highlighted how IoT can revitalize and restore outdated business models, making them profitable ...
SYS-CON Events announced today that Isomorphic Software will exhibit at DevOps Summit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Isomorphic Software provides the SmartClient HTML5/AJAX platform, the most advanced technology for building rich, cutting-edge enterprise web applications for desktop and mobile. SmartClient combines the productivity and performance of traditional desktop software with the simp...
"When you think about the data center today, there's constant evolution, The evolution of the data center and the needs of the consumer of technology change, and they change constantly," stated Matt Kalmenson, VP of Sales, Service and Cloud Providers at Veeam Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 19th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world and ThingsExpo Silicon Valley Call for Papers is now open.